Literature DB >> 19202786

Simultaneous determination of bioactive xanthone glycosides and norlignans from ethanolic extract of Anemarrhena asphodeloides by liquid chromatography.

M Nurul Islam1, Hye Hyun Yoo, Jun Lee, Joo Won Nam, Eun Kyoung Seo, Changbae Jin, Dong-Hyun Kim.   

Abstract

The rhizomes of Anemarrhena asphodeloides Bunge (Liliaceae) are prescribed as crude drugs in herbal medication for the treatment of various diseases such as diabetes, inflammation, and platelet aggregation inhibition. A simple, sensitive, and precise reversed-phase liquid chromatographic method was developed to study the quantitative determination of 5 bioactive compounds from these rhizomes, namely, neomangiferin, mangiferin, isomangiferin, nyasol, and methylnyasol. Chromatographic analysis was performed on Capcell Pak C18 column (150 x 4.6 mm, 3 microm) with a mobile phase consisting of acetonitrile, methanol, and 0.1% formic acid at a flow rate of 1.00 mL/min. Quantitation was performed using a UV-visible detector at 260 nm. The method for the determination of reported medicinal agents was accurate and reproducible. Excellent linear behavior was observed over the investigated concentration range of 2.5-100.0 microg/mL for neomangiferin; 1.5-60.0 microg/mL for mangiferin; 0.5-20.0 microg/mL for nyasol; and 0.2-20.0 microg/mL for methylnyasol; correlation coefficient > 0.99. The intraday and interday precision over the concentration range of compounds was < 6.6% (relative standard deviation) and accuracy was between 94.9 and 109.3%. This method can be successfully applied for the analysis of medicinal compounds from the ethanolic extract of A. asphodeloides Bunge.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19202786

Source DB:  PubMed          Journal:  J AOAC Int        ISSN: 1060-3271            Impact factor:   1.913


  1 in total

1.  Isomangiferin, a Novel Potent Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor, Suppresses Breast Cancer Growth, Metastasis and Angiogenesis.

Authors:  Banghua Wang; Jia Shen; Zexia Wang; Jianxia Liu; Zhifeng Ning; Meichun Hu
Journal:  J Breast Cancer       Date:  2018-03-23       Impact factor: 3.588

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.